Patent intelligence · US
US 12329747
Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species
Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant spe…
Patent details — US 12329747
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 17, 2025
- Expiration
- Jun 12, 2045
- Applicant
- Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College
- Claims
- 13
- CPC classes
- A61K, A61K31/43, A61K31/431
Quick answer
US 12329747 (Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species) is held by Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College. Status: granted. Granted Jun 17, 2025. Expires Jun 12, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College
- Grant date
- Expiration
- Claims
- 13
- CPC classes
- A61K, A61K31/43, A61K31/431
More from Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 12329747?
US 12329747 (Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species) is held by Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College. Status: granted. Granted Jun 17, 2025. Expires Jun 12, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12329747?
Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 12329747 expire?
Our index shows an expiration date of Jun 12, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.